Edit the Templates Details Before clicking Use this template for the one you want, you can also tick the Keep example content box
Barriers and facilitators to weight management in overweight and obese women living in Australia with PCOS: a qualitative study
As a result of being peptides, GLP-1 RAs typically have to be given by subcutaneous (s.c.) administration as twice daily (BID) (exenatide) [15, 16], once daily (OD) (lixisenatide [17, 18] and liraglutide [19, 20]) or once weekly (OW) (dulaglutide [21, 22], prolonged-release exenatide [23, 24] and semaglutide [25, 26]) dosing regimens, based on their in vivo half-lives [6]
Some research suggests MOTS-c may influence signaling associated with muscle metabolism
The role of acetylation and deacetylation in cancer metabolism
As of March 2026, a higher dose of 7.2 mg per week has been approved for eligible patients in the U.S